Century Therapeutics Inc (IPSC) concluded trading on Wednesday at a closing price of $4.16, with 4.18 million shares of worth about $17.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 61.24% during that period and on Wednesday the price saw a loss of about -9.76%. Currently the company’s common shares owned by public are about 58.47M shares, out of which, 23.50M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 11 times over the past 12 months. They bought 629,600 shares in 6 of the transactions. In 5 selling transactions, insiders dumped 182,285 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 4.6100, or with a loss of -9.76%. Stock saw a price change of -6.09% in past 5 days and over the past one month there was a price change of 0.97%. Year-to-date (YTD), IPSC shares are showing a performance of 25.30% which decreased to -12.79% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.28 but also hit the highest price of $5.34 during that period. The average intraday trading volume for Century Therapeutics Inc shares is 179.56K. The stock is currently trading -4.85% below its 20-day simple moving average (SMA20), while that difference is up 14.57% for SMA50 and it goes to 50.69% higher than SMA200.
Century Therapeutics Inc (NASDAQ: IPSC) currently have 58.47M outstanding shares and institutions hold larger chunk of about 29.53% of that.
The stock has a current market capitalization of $248.93M and its 3Y-monthly beta is at 1.41. It has posted earnings per share of -$2.19 in the same period. It has Quick Ratio of 8.50 while making debt-to-equity ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IPSC, volatility over the week remained 6.84% while standing at 8.85% over the month.
Analysts are in expectations that Century Therapeutics Inc (IPSC) stock would likely to be making an EPS of -$0.55 in the current quarter, while forecast for next quarter EPS is -$0.59 and it is -$2.2 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.7 which is -$0.4 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.53 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 7.80% while it is estimated to decrease by -5.32% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on August 28, 2023 offering a Neutral rating for the stock and assigned a target price range of between $28 and $5 to it. Coverage by Chardan Capital Markets stated Century Therapeutics Inc (IPSC) stock as a Buy in their note to investors on December 27, 2022, suggesting a price target of $19 for the stock. On October 31, 2022, Guggenheim Initiated their recommendations, while on October 10, 2022, Canaccord Genuity Initiated their ratings for the stock with a price target of $28. Stock get a Buy rating from H.C. Wainwright on May 23, 2022.
